Abstract No. 109 Sclerotherapy: An Effective Way to Treat Vascular Malformation—ISSVA Grade 2 and 3

Vascular malformations are caused by a disturbance in the late stages of angiogenesis (truncal stage) and result in the persistence of arteriovenous anastomosis present during embryonic life. Recently, increasing interest has emerged in minimally invasive treatment, and McCafferty and Lee consider nonsurgical treatment such as sclerotherapy to be an important option for the treatment of vascular malformations. The aim of this study was to evaluate treatment response after sclerotherapy in patients with Vascular Malformations and assess the clinical, radiological response and quality index of life in patients with ISSVA (International Society for the Study of Vascular Anomalies) Type II and III Vascular Malformations.

Vascular malformations are caused by a disturbance in the late stages of angiogenesis (truncal stage) and result in the persistence of arteriovenous anastomosis present during embryonic life. Recently, increasing interest has emerged in minimally invasive treatment, and McCafferty and Lee consider nonsurgical treatment such as sclerotherapy to be an important option for the treatment of vascular malformations. The aim of this study was to evaluate treatment response after sclerotherapy in patients with Vascular Malformations and assess the clinical, radiological response and quality index of life in patients with ISSVA (International Society for the Study of Vascular Anomalies) Type II and III Vascular Malformations.